Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy– a report of two cases

Fig. 1

Disease course timeline for patient 1. -Pleural effusion requiring thoracentesis. -Pericardiocentesis for pericardial tamponade. -First noted to have pericardial effusion on imaging. SCLC – Small Cell Lung Cancer, EP – period during which disease was controlled using several cycles of Etoposide + Platinum, 2nd and 3rd line – period during which several second and third line agents were used including topotecan, everolimus, temozolamide, docetaxel and sunitinib

Back to article page